B型肝炎ウイルス（HBV）予防ワクチン：企業動向...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers – Global Issues 17
4 Current and Future Players 24
4.1 Overview 24
4.2 Trends in Corporate Strategy 28
4.3 Company Profiles 30
4.3.1 GSK 30
4.3.2 Merck 34
4.3.3 Sanofi 36
4.3.4 Kaketsuken 39
4.3.5 Dynavax Technologies 40
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 55
5.3 Methodology 57
5.4 Forecasting Methodology 57
5.4.1 Patient Populations Targeted for Vaccination 58
5.4.2 Vaccination Coverage Rates 61
5.4.3 Vaccinated Patients 62
5.4.4 Regulatory Approval vs. Advisory Committee Recommendation 62
5.4.5 General Pricing Assumptions 63
5.5 Physicians and Specialists Included in this Study 64
5.5.1 Interviews of Key Opinion Leaders (KOLs) 64
5.5.2 Online Survey of High-Prescribing Physicians (non-KOLs) 66
5.6 About the Authors 67
5.6.1 Analyst 67
5.6.2 Therapy Area Director 67
5.6.3 Global Head of Healthcare 68
5.7 About GlobalData 69
5.8 Disclaimer 69